CRMD (Cormedix) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CRMD Cormedix Inc CRMD
33 GF Score
Price $7.87
! 6 Warning Signs
View Full Analysis

What is Cormedix FFO per Share?

FFO per Share only applies to REITs.

CRMD
33GF Score
Cormedix Inc CRMD
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cormedix Business Description

Other Exchanges 19KA:Germany
Address 389 Interpace Parkway, Suite 450, Parsippany, NJ, USA, 07054
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
33GF Score

Get the complete analysis for CRMD

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.87
Price